Home
>
National Drug Code (NDC)
>
METHOTREXATE
METHOTREXATE - 67253-320-36 - (METHOTREXATE)
Drug Information of METHOTREXATE
| Product NDC: | 67253-320 |
| Proprietary Name: | METHOTREXATE |
| Non Proprietary Name: | METHOTREXATE |
| Active Ingredient(s): | 2.5 mg/1 & nbsp; METHOTREXATE |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of METHOTREXATE
| Product NDC: | 67253-320 |
| Labeler Name: | DAVA Pharmaceuticals, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA008085 |
| Marketing Category: | NDA |
| Start Marketing Date: | 19531207 |
Package Information of METHOTREXATE
| Package NDC: | 67253-320-36 |
| Package Description: | 36 TABLET in 1 BOTTLE (67253-320-36) |
NDC Information of METHOTREXATE
| NDC Code | 67253-320-36 |
| Proprietary Name | METHOTREXATE |
| Package Description | 36 TABLET in 1 BOTTLE (67253-320-36) |
| Product NDC | 67253-320 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | METHOTREXATE |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 19531207 |
| Marketing Category Name | NDA |
| Labeler Name | DAVA Pharmaceuticals, Inc. |
| Substance Name | METHOTREXATE SODIUM |
| Strength Number | 2.5 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Folate Analog Metabolic Inhibitor [EPC],Folic Acid Metabolism Inhibitors [MoA] |
